ATE81470T1 - Laktogener leber-faktor. - Google Patents

Laktogener leber-faktor.

Info

Publication number
ATE81470T1
ATE81470T1 AT88902741T AT88902741T ATE81470T1 AT E81470 T1 ATE81470 T1 AT E81470T1 AT 88902741 T AT88902741 T AT 88902741T AT 88902741 T AT88902741 T AT 88902741T AT E81470 T1 ATE81470 T1 AT E81470T1
Authority
AT
Austria
Prior art keywords
liver
factor
lactogen
lactogenic
present
Prior art date
Application number
AT88902741T
Other languages
English (en)
Inventor
L Stephen Frawley
Original Assignee
Univ South Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Carolina filed Critical Univ South Carolina
Application granted granted Critical
Publication of ATE81470T1 publication Critical patent/ATE81470T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/843Digestive system
    • Y10S530/846Liver
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/773Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/788Of specified organic or carbon-based composition
    • Y10S977/802Virus-based particle
    • Y10S977/803Containing biological material in its interior
    • Y10S977/804Containing nucleic acid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88902741T 1987-03-06 1988-03-07 Laktogener leber-faktor. ATE81470T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/022,893 US4895833A (en) 1987-03-06 1987-03-06 Liver lactogenic factor
PCT/US1988/000673 WO1988006453A1 (en) 1987-03-06 1988-03-07 Liver lactogenic factor
EP88902741A EP0348429B1 (de) 1987-03-06 1988-03-07 Laktogener leber-faktor

Publications (1)

Publication Number Publication Date
ATE81470T1 true ATE81470T1 (de) 1992-10-15

Family

ID=21811984

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88902741T ATE81470T1 (de) 1987-03-06 1988-03-07 Laktogener leber-faktor.

Country Status (7)

Country Link
US (1) US4895833A (de)
EP (1) EP0348429B1 (de)
JP (1) JPH02502995A (de)
AT (1) ATE81470T1 (de)
AU (1) AU622613B2 (de)
DE (1) DE3875341T2 (de)
WO (1) WO1988006453A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2370154A (en) * 1941-01-31 1945-02-27 Schering Corp Process for the isolation of the lactogenic hormone

Also Published As

Publication number Publication date
US4895833A (en) 1990-01-23
AU622613B2 (en) 1992-04-16
WO1988006453A1 (en) 1988-09-07
DE3875341T2 (de) 1993-04-15
EP0348429A4 (de) 1990-04-10
EP0348429B1 (de) 1992-10-14
EP0348429A1 (de) 1990-01-03
DE3875341D1 (de) 1992-11-19
JPH02502995A (ja) 1990-09-20
AU1482788A (en) 1988-09-26

Similar Documents

Publication Publication Date Title
ATE40884T1 (de) Zwischenverbindungen fuer die herstellung von omeprazol.
DE3787020D1 (de) Herstellung von m-csf.
DE3762616D1 (de) Hydrierung von methylendianilin zur herstellung von bis-(para-aminocyclohexyl)methanen.
ATE72660T1 (de) Herstellung von zeolith-l.
DE3576504D1 (de) Herstellung von ethylenoxid.
DE3486433D1 (de) Bayer-Verfahren zur Herstellung von Aluminiumhydroxid
DE3581458D1 (de) Herstellung von maleinsaeureanhydrid.
ATE41034T1 (de) Herstellung von protein a.
IT1202447B (it) Procedimento per la produzione di benzina
DE3482982D1 (de) Herstellung von l-aminosaeuren durch transaminierung.
DE69123298D1 (de) Leistungshalbleiteranordnung, geeignet zur Automation der Herstellung
FI890889A7 (fi) Kallikreinin tuottaminen
DE3789812D1 (de) Poröser wafer zur segmentierten herstellung von bipolymeren.
AT388494B (de) Bausatz zur herstellung von staendern fuer kleiderstuecke u.dgl.
DE3381730D1 (de) Herstellung von halbleiteranordnungen.
DE3884654D1 (de) Herstellung von chromogenischen Cryptahemispheranden.
DE3875341D1 (de) Laktogener leber-faktor.
DE3581238D1 (de) Mikrobiologische herstellung von l-phenylalanin.
DE3889371D1 (de) Verfahren zur Herstellung von supraleitenden Keramiken.
DE3750349D1 (de) Anordnung zur Herstellung von Dünnschichten.
DE3583625D1 (de) Erzeugung von bauholz.
ATE66931T1 (de) Verfahren zur scheidung und isolierung von nosiheptid.
DE3772237D1 (de) Herstellung von sekundaeraminen aus olefinen und primaeraminen.
DE3670063D1 (de) Herstellung von thioantimonaten.
SU1135378A1 (ru) Способ изготовления биполярных интегральных транзисторов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties